Skip to NavigationSkip to content

COVID

COVID-19 patients are experiencing long-term effects from the virus

Photo by Mohsen Atayi

Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.

Coronavirus fake news has led to hundreds of deaths, according to a new study

Photo by Axelle B

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according to researchers.

Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

Photo by Senior Airman Areca Wilson

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine.

The final trials into its safety continue and the approval comes just two months after human trials began. The speed of its development and approval has left many concerned political motivations are the driving factor behind the vaccine. Putin himself commented on the vaccine, saying: “I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks.”

Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatment

U.S. Army photo by Jason W. Edwards

Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack of evidence for its effectiveness.           

EU agrees deal with Sanofi for COVID-19 vaccine supply

Photo by MPD01605

The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow the trading bloc’s members to purchase the vaccines if and when it gets an approval.

This is part of a wider strategy the EU is pursuing. They have set aside a fund of $2.4 billion to strike separate deals with multiple pharmaceutical companies developing vaccines to ensure the EU’s 450 million citizens have access to a potential treatment.

Face shields did not protect people from a COVID-19 outbreak in Switzerland but masks did, according to health officials

Photo by Steve Pisano https://bit.ly/32QmkUP

Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be ineffective.

Infections were reported at a hotel in the Graübunden region, where multiple employees tested positive for the virus. All those who had been infected were only wearing face shields as protection while no one who had worn a mask became infected.

India begins human trials of its first homegrown coronavirus vaccine

Photo by Senior Airman Areca Wilson

India has begun human trials of its first internally developed vaccine for COVID-19.

The Indian Council of Medical Research have allowed both Phase 1 and 2 human trials of Covaxin, the experimental vaccine developed by Bharat Biotech. Lokesh Sharma, the Council’s media coordinator, said: “Trials at some sites began yesterday or before, at some places it will begin today and at some sites it will start tomorrow.”

Trump administration orders hospitals to stop sending COVID-19 data to the CDC

Photo by Jim Gathany

The Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention (CDC) and instead to a central database in Washington, DC.

This was announced on the Department of Health and Human Services website, and this department will take over from the CDC to collect daily reports on the number of available beds and ventilators and other coronavirus related information.  Many health experts fear this will lead to the Trump administration either withholding data from the public or politicising it.

UK lockdown caused infection ‘R’ rate to drop as low as 0.57, according to a new study

Photo by Alex Borland

A new study showed that the coronavirus infection rate hit its lowest point one month before lockdown restrictions were lifted.

A study conducted by the Imperial College London, tracked the prevalence of the virus during May and reported that the infection rate halved every eight to nine days during this month. This placed the overall reproduction rate to 0.57, which is lower than previously reported. This means for every infected person, they would transmit the virus to 0.57 other people.

The World Health Organization says COVID-19 can linger in the air indoors

The World Health Organization has recoginised that COVID-19 can be transmitted indoors by droplets in the air, reversing its previous stance.

This U-turn comes after 239 scientists from over 30 countries urged the WHO to put more focus on assessing the possible airborne spread of COVID-19. Previously, they had described this type of transmission as unlikely unless it came after certain medical procedures carried out on coronavirus patients.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches